FDA Says 'Candy-Like' Children’s Drugs Need More Secure Packaging

Experts debate the safety of candy-like medicines for children and propose child-resistant packaging solutions during FDA meeting.

Pexels Ivan J Long 1375810
Ivan J Long

On Halloween, it’s only fitting that we cover a story about kids and candy, right? According to a recent STAT News article, the FDA recently held a meeting to discuss the use of "candy-like" nonprescription drug products, including gummies and other forms, particularly for children who may have difficulty swallowing pills. The debate explored the potential benefits and risks associated with such products. Though there were arguments in favor of using medicated gummies for dental sedation in children, most speakers highlighted potential pitfalls, such as accidental overdose. Historically, there has been a 500% increase in pediatric overdoses linked to kid-friendly aspirin marketing, along with a rise in emergency room visits due to pediatric melatonin exposures.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026